All News

Discover the vision and goals of Crux Biolabs' new CEO in our in-depth interview. Learn about their background in the pharmaceutical industry and the company's…

MesoScale Discovery (MSD) immunoassays are used to measure the concentration of proteins or other molecules in biological samples. They detect multiple analytes in a single sample and are superior to…

When it comes to clinical trials, it is all about the patient! Good Clinical Practice – or GCP as it is known - is a…

As so many of our partners have thrilled since earlier in the year when we launched our capability to provide 21 colour flow cytometry, we…

When it comes to places to conduct research, few places globally offer better incentives than Australia. Known as the “Australian advantage”, not only does the…

After repeated inquiries from our customer base, Crux Biolabs are pleased to announce their expansion into chemistry analytical services in 2023. These services will be…

We are pleased to be attending AusBiotech 2022 in Perth! If you are also attending this year's event, get in touch with any of our…

Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector  Crux Biolabs is a decade-old Australian leader in bioanalytics, customised…

Crux Biolabs has recently passed 2 External Quality Assurance Programs (EQAPs) and we’d like to congratulate the fantastic scientists involved. Livleen Kaur successfully passed Crux’s…

We are looking for a scientist to join our growing team. We expect the scientist in this position to perform process whole blood samples to PBMCs…